Viking Therapeutics, Inc. (VKTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-03

Viking Therapeutics, Inc. (VKTX) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-03. 2 Form 8-K material event filings were reported by VKTX in the last 90 days. InsiderAlpha tracks every VKTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Viking Therapeutics, Inc. (VKTX)

SEC CIK0001607678

90-Day SEC Filing Activity

Form 4 filings (90d)1
Form 8-K filings (90d)2
Latest Form 4 filing2026-06-03

Recent VKTX Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Aubuchon Neil WilliamChief Commercial OfficerP — Open-market purchase4.5K$33.50$150KSEC
Mancini MariannaChief Operating OfficerS — Open-market sale10.5K$34.22$359KSEC
ZANTE GREGChief Financial OfficerS — Open-market sale32.0K$32.30$1.03MSEC
Lian BrianPresident & CEOS — Open-market sale53.3K$33.38$1.78MSEC
Lian BrianPresident & CEOS — Open-market sale6.4K$35.07$224KSEC
Mancini MariannaChief Operating OfficerS — Open-market sale13.6K$33.37$454KSEC
Mancini MariannaChief Operating OfficerS — Open-market sale1.6K$35.07$56KSEC
ZANTE GREGChief Financial OfficerS — Open-market sale10.3K$34.24$353KSEC
Lian BrianPresident & CEOS — Open-market sale132.5K$32.29$4.28MSEC
ZANTE GREGChief Financial OfficerS — Open-market sale1.5K$32.09$48KSEC
Mancini MariannaChief Operating OfficerS — Open-market sale32.0K$32.29$1.03MSEC
ZANTE GREGChief Financial OfficerS — Open-market sale13.9K$33.38$464KSEC
Lian BrianPresident & CEOS — Open-market sale41.3K$34.22$1.41MSEC
Lian BrianPresident & CEOA — Grant or award78.4K$0.00—SEC
ZANTE GREGChief Financial OfficerA — Grant or award41.0K$0.00—SEC

All transactions sourced from SEC EDGAR Form 4 filings for Viking Therapeutics, Inc. (VKTX). Updated in real time as new filings are submitted to the SEC.

Most-Active VKTX Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Chen Hubert C1—

Recent VKTX Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in VKTX insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

VKTX Insider Trading — FAQ

What is the latest insider trade for VKTX?
Viking Therapeutics, Inc. (VKTX) had 1 insider filings in the last 90 days, with the most recent on 2026-06-03. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying VKTX stock?
0 insider purchases of VKTX were filed in the last 90 days.
How many insiders are selling VKTX stock?
0 insider sales of VKTX were filed in the last 90 days.
Where can I see VKTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every VKTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live VKTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.